Pavel Souček

9.2k total citations · 1 hit paper
201 papers, 6.1k citations indexed

About

Pavel Souček is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pavel Souček has authored 201 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Molecular Biology, 88 papers in Oncology and 72 papers in Cancer Research. Recurrent topics in Pavel Souček's work include Drug Transport and Resistance Mechanisms (41 papers), Pharmacogenetics and Drug Metabolism (39 papers) and Pancreatic and Hepatic Oncology Research (24 papers). Pavel Souček is often cited by papers focused on Drug Transport and Resistance Mechanisms (41 papers), Pharmacogenetics and Drug Metabolism (39 papers) and Pancreatic and Hepatic Oncology Research (24 papers). Pavel Souček collaborates with scholars based in Czechia, Japan and United States. Pavel Souček's co-authors include Ivan Gut, F. Peter Guengerich, Pavel Vodička, Beatrice Mohelníková-Duchoňová, Pavel Anzenbacher, David J. Hughes, Václav Liška, Tereza Kunická, Veronika Brynychová and Ľudmila Vodičková and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Pavel Souček

198 papers receiving 6.0k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome

2014 390 citations Pavel Souček, Václav Liška et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pavel Souček Czechia	41	3.1k	2.0k	1.7k	1.1k	842	201	6.1k
Kei Nakachi Japan	47	4.0k 1.3×	1.9k 1.0×	1.5k 0.9×	706 0.7×	943 1.1×	155	9.3k
Mark A. Doll United States	41	3.2k 1.0×	711 0.4×	1.9k 1.1×	668 0.6×	463 0.5×	160	5.2k
William T. Melvin United Kingdom	39	2.2k 0.7×	1.7k 0.9×	1.5k 0.9×	1.6k 1.5×	551 0.7×	94	5.2k
Chantal Guillemette Canada	50	4.0k 1.3×	2.2k 1.1×	869 0.5×	2.9k 2.7×	1.1k 1.3×	187	8.3k
Katsumi Imaida Japan	41	2.5k 0.8×	1.0k 0.5×	1.9k 1.1×	531 0.5×	423 0.5×	251	6.3k
John DiGiovanni United States	56	6.6k 2.1×	3.5k 1.8×	3.1k 1.8×	751 0.7×	734 0.9×	322	12.6k
Po‐Lin Kuo Taiwan	55	4.8k 1.5×	1.5k 0.8×	1.6k 0.9×	777 0.7×	262 0.3×	199	9.0k
Michael J. Wargovich United States	46	2.6k 0.9×	1.5k 0.7×	833 0.5×	608 0.6×	780 0.9×	151	7.1k
Sharad S. Singhal United States	48	5.3k 1.7×	1.8k 0.9×	785 0.5×	453 0.4×	449 0.5×	197	7.6k
Daniel W. Rosenberg United States	41	3.1k 1.0×	1.7k 0.8×	1.2k 0.7×	257 0.2×	755 0.9×	171	6.4k

Countries citing papers authored by Pavel Souček

Since Specialization

Citations

This map shows the geographic impact of Pavel Souček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Souček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Souček more than expected).

Fields of papers citing papers by Pavel Souček

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavel Souček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Souček. The network helps show where Pavel Souček may publish in the future.

Co-authorship network of co-authors of Pavel Souček

This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Souček. A scholar is included among the top collaborators of Pavel Souček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Souček. Pavel Souček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holý, Petr, Viktor Hlaváč, Lukáš Rob, et al.. (2024). Targeted DNA sequencing of high‐grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression. International Journal of Cancer. 155(1). 104–116. 1 indexed citations

Souček, Pavel, et al.. (2024). The use of patient-derived xenografts and patient-derived organoids in the search for new therapeutic regimens for pancreatic carcinoma. A review. Biomedicine & Pharmacotherapy. 182. 117750–117750. 6 indexed citations

Hlaváč, Viktor, Lenka Červenková, Petr Holý, et al.. (2023). Exome Sequencing of Paired Colorectal Carcinomas and Synchronous Liver Metastases for Prognosis and Therapy Prediction. JCO Precision Oncology. 7(7). e2200557–e2200557. 2 indexed citations

Václavíková, Radka, Milan Hora, Ondřej Hes, et al.. (2023). Association of lncRNA and transcriptome intersections with response to targeted therapy in metastatic renal cell carcinoma. Oncology Letters. 26(3). 365–365. 2 indexed citations

Hlaváč, Viktor, Petr Holý, Radka Václavíková, et al.. (2022). Whole-exome sequencing of epithelial ovarian carcinomas differing in resistance to platinum therapy. Life Science Alliance. 5(12). e202201551–e202201551. 4 indexed citations

Holý, Petr, Marie Ehrlichová, Changwei Wang, et al.. (2021). The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes. International Journal of Molecular Sciences. 23(1). 73–73. 13 indexed citations

Hlaváč, Viktor, Radka Václavíková, Veronika Brynychová, et al.. (2021). Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response. International Journal of Molecular Sciences. 22(6). 2826–2826. 10 indexed citations

Madden, Stephen F., James Hawley, Sara Charmsaz, et al.. (2021). Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy. Clinical Cancer Research. 27(14). 3980–3989. 5 indexed citations

Hlaváč, Viktor, Beatrice Mohelníková-Duchoňová, Martin Loveček, et al.. (2020). Targeted Sequencing of Pancreatic Adenocarcinomas from Patients with Metachronous Pulmonary Metastases. Genes. 11(12). 1391–1391. 1 indexed citations

10.

Hlaváč, Viktor, Radka Václavíková, Veronika Brynychová, et al.. (2020). Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response. International Journal of Molecular Sciences. 21(24). 9556–9556. 22 indexed citations

11.

Loveček, Martin, Markéta Janatová, Pavel Skalický, et al.. (2019). Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations. Cancer Management and Research. Volume 11. 599–609. 4 indexed citations

12.

Ueng, Yune‐Fang, et al.. (2019). Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data. The Journal of Steroid Biochemistry and Molecular Biology. 197. 105566–105566. 27 indexed citations

13.

Vrána, David, Viktor Hlaváč, Radka Václavíková, et al.. (2018). ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. International Journal of Molecular Sciences. 19(3). 868–868. 25 indexed citations

14.

Hlaváč, Viktor, Veronika Brynychová, Kateřina Kopečková, et al.. (2018). Use of Germline Genetic Variability for Prediction of Chemoresistance and Prognosis of Breast Cancer Patients. Cancers. 10(12). 511–511. 16 indexed citations

15.

Havránek, Ondřej, Petra Kleiblová, J. Hojný, et al.. (2015). Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma. PLoS ONE. 10(10). e0140819–e0140819. 36 indexed citations

16.

Souček, Pavel, et al.. (2015). Whole Exome Sequencing Analysis of ABCC8 and ABCD2 Genes Associating With Clinical Course of Breast Carcinoma. Physiological Research. 64(Suppl 4). S549–S557. 10 indexed citations

17.

Hlaváč, Viktor, Veronika Brynychová, Radka Václavíková, et al.. (2014). The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients. Medicine. 93(28). e255–e255. 24 indexed citations

18.

Slyšková, Jana, Vlasta Korenková, Andrew Collins, et al.. (2012). Functional, Genetic, and Epigenetic Aspects of Base and Nucleotide Excision Repair in Colorectal Carcinomas. Clinical Cancer Research. 18(21). 5878–5887. 62 indexed citations

19.

Ueng, Yune‐Fang, Chien‐Chih Chen, Tsung‐Yun Liu, et al.. (2011). Mechanism‐based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in micein vivo. British Journal of Pharmacology. 163(6). 1250–1262. 17 indexed citations

20.

Gillam, Elizabeth M. J., Anna Marie A. Aguinaldo, L. Notley, et al.. (2000). Formation of indigo by recombinant mammalian cytochrome P450. The FASEB Journal. 14(8). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact